Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07646262
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu UniversityRecruitingNot Applicable
NCT07646262Recruiting
Not Applicable
Gluten-Free vs Mediterranean Diet in Rheumatoid ArthritisHasan Kalyoncu University
NCT07643974
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research InstituteNot Yet RecruitingEarly Phase 1
NCT07643974Not Yet Recruiting
Early Phase 1
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTDMedstar Health Research I...
NCT07645638
Virtual Reality Cognitive Stimulation for Alzheimer'sUniversidad de BurgosCompletedNot Applicable
NCT07645638Completed
Not Applicable
Virtual Reality Cognitive Stimulation for Alzheimer'sUniversidad de Burgos
NCT07646080
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma ProtuberansYanjie Zhang, MDNot Yet RecruitingPhase 2
NCT07646080Not Yet Recruiting
Phase 2
Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemothera...Yanjie Zhang, MD
NCT07644975
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantitis: A Randomized Clinical TrialIstanbul UniversityNot Yet RecruitingNot Applicable
NCT07644975Not Yet Recruiting
Not Applicable
Electrolytic Surface Decontamination in the Surgical Treatment of Peri-implantit...Istanbul University
NCT07646509
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic Symptom DisorderUniversity of ViennaRecruitingNot Applicable
NCT07646509Recruiting
Not Applicable
An Ecological Momentary Intervention for the Reduction of Impairment in Somatic...University of Vienna
NCT07645339
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier RepairL'OrealActive Not RecruitingNot Applicable
NCT07645339Active Not Recruiting
Not Applicable
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier...L'Oreal
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07645131
Development of a Mobile Health Intervention to Support Functioning of Veterans With Substance Use DisordersVA Office of Research and DevelopmentNot Yet RecruitingNot Applicable
NCT07645131Not Yet Recruiting
Not Applicable
Development of a Mobile Health Intervention to Support Functioning of Veterans W...VA Office of Research and...
NCT07645274
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led, Patient Navigation Program (PARTNER-MH 2.0)Indiana UniversityNot Yet RecruitingNot Applicable
NCT07645274Not Yet Recruiting
Not Applicable
Improving Mental Healthcare Outcomes for Minoritized Veterans Through a Peer-led...Indiana University
NCT07645300
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Medical CenterNot Yet RecruitingPhase 2
NCT07645300Not Yet Recruiting
Phase 2
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD TrialMichael E. DeBakey VA Med...
NCT07644169
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG) in Healthy Adults Following PG ExposureAmerican Beverage AssociationNot Yet RecruitingNot Applicable
NCT07644169Not Yet Recruiting
Not Applicable
A Clinical Trial to Assess the Pharmacokinetic Profile of Propylene Glycol (PG)...American Beverage Associa...
NCT07644754
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of MunichNot Yet RecruitingNot Applicable
NCT07644754Not Yet Recruiting
Not Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level...Ludwig-Maximilians - Univ...
NCT07645560
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 2
NCT07645560Not Yet Recruiting
Phase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After...Beijing Tiantan Hospital
NCT07645235
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenBiomedical Advanced Research and Development AuthorityNot Yet RecruitingPhase 1
NCT07645235Not Yet Recruiting
Phase 1
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Wom...Biomedical Advanced Resea...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644104
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang UniversityNot Yet RecruitingNot Applicable
NCT07644104Not Yet Recruiting
Not Applicable
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang University
NCT07644624
Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)Hospital Universitari de BellvitgeNot Yet RecruitingNot Applicable
NCT07644624Not Yet Recruiting
Not Applicable
Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Sur...Hospital Universitari de...
NCT07645612
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra MalaysiaNot Yet RecruitingNot Applicable
NCT07645612Not Yet Recruiting
Not Applicable
A Just-in-Time Digital Learning Platform for Teacher Oral Health TrainingUniversiti Putra Malaysia
Result Breakdown
Not yet recruiting14 (70%)
Recruiting4 (20%)
Completed1 (5%)
Active, not recruiting1 (5%)
not_applicable12 (60%)
Phase 24 (20%)
Phase 12 (10%)
Early Phase 11 (5%)
Not Specified1 (5%)